Global Blood Therapeutics - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsGlobal Blood Therapeutics

Global Blood Therapeutics(GBT)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Oxbryta	Voxelotor	2019-11-25	2032-2037	Anemia , Sickle cell anemia , Hemolytic anemia

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

renal insufficiency

,

healthy volunteers/patients

,

,

,

idiopathic pulmonary fibrosis

,

pulmonary fibrosis

,

chronic renal insufficiency

,

kidney diseases

,

sickle cell anemia

,

venous thromboembolism

,

thromboembolism

,

pulmonary embolism

,

,

,

venous thrombosis

,

hypersensitivity

,

,

sickle cell anemia

,

healthy volunteers/patients

,

knee osteoarthritis

,

,

,

atrial fibrillation

,

venous thrombosis

,

venous thromboembolism

,

thromboembolism

,

,

chronic kidney failure

,

postmenopausal osteoporosis

,

multiple sclerosis

,

relapsing-remitting multiple sclerosis

,

,

pulmonary embolism

,

,

,

,

,

,

hepatocellular carcinoma

,

liver neoplasms

,

,

,

vascular calcification

,

cardiac surgical procedures

,

prediabetic state

,

diabetes mellitus

,

,

,

vitamin k deficiency

,

drug-related side effects and adverse reactions

,

heart valve diseases

,

metabolic bone diseases

,

medication adherence

,

,

,

hyperhomocysteinemia

,

intracranial hemorrhages

,

traumatic intracranial hemorrhage

,

chronic renal insufficiency

,

kidney diseases

,

cardiovascular diseases

,

,

,

,

,

,

atherosclerosis

,

,

potassium deficiency

,

,

oxidative stress

,

periodontal diseases

,

disease progression

,

,

,

,

,

cardiometabolic risk factors

,

cerebral hemorrhage

,

hypertensive intracranial hemorrhage

,

hodgkin disease

,

,

pancreatic neoplasms

,

pancreatic ductal carcinoma

,

,

colonic neoplasms

,

rectal neoplasms

,

carotid artery diseases

,

atherosclerosis

,

,

hematologic neoplasms

,

sezary syndrome

,

b-cell chronic lymphocytic leukemia

,

prolymphocytic leukemia t-cell

,

t-cell lymphoma

,

prolymphocytic leukemia

,

t-cell lymphoma peripheral

,

t-cell lymphoma cutaneous

,

prolymphocytic leukemia b-cell

,

renal cell carcinoma

,

kidney neoplasms

,

gastrointestinal neoplasms

,

biliary tract neoplasms

,

hypercholesterolemia

,

,

,

hyperlipidemias

,

,

colorectal neoplasms

,

hyperlipoproteinemias

,

postmenopausal osteoporosis

,

hyperlipoproteinemia type v

,

familial combined hyperlipidemia

,

stomach neoplasms

,

non-small-cell lung carcinoma

,

,

,

esophageal neoplasms

,

type 2 diabetes mellitus

,

diabetes mellitus

,

vitamin d deficiency

,

non-hodgkin lymphoma

,

,

esophageal squamous cell carcinoma

,

hyperlipoproteinemia type ii

,

,

,

,

cardiovascular diseases

,

coronary disease

,

coronary artery disease

,

myocardial ischemia

,

,

peripheral arterial disease

,

peripheral vascular diseases

,

heart transplantation

,

polycystic ovary syndrome

,

,

,

atopic dermatitis

,

,

sickle cell anemia

,

healthy volunteers/patients

© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use